
Keywords: Type I hypersensitivity; allergen-specific immunotherapy; mouse models; mast cells; basophils; ASIT; Allergen-specific immunotherapy; BrdU; 5-Bromo-2â²-deoxyuridine; FoxP3; Forkhead box protein 3; OVA; Ovalbumin; PerCP; Peridinin-chlorophyll-protein comp